Cargando…
Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase
High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. H...
Autores principales: | Yang, Shuang, Zheng, Xiangdong, Lu, Chao, Li, Guo-Min, Allis, C. David, Li, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973290/ https://www.ncbi.nlm.nih.gov/pubmed/27474439 http://dx.doi.org/10.1101/gad.284323.116 |
Ejemplares similares
-
Cryo-EM structure of SETD2/Set2 methyltransferase bound to a nucleosome containing oncohistone mutations
por: Liu, Yingying, et al.
Publicado: (2021) -
The expanding landscape of ‘oncohistone’ mutations in human cancers
por: Nacev, Benjamin A., et al.
Publicado: (2019) -
Molecular basis for histidine N3-specific methylation of actin H73 by SETD3
por: Zheng, Yihui, et al.
Publicado: (2020) -
Oncohistone mutations enhance chromatin remodeling and alter cell fates
por: Bagert, John D., et al.
Publicado: (2021) -
Structural basis for the target specificity of actin histidine methyltransferase SETD3
por: Dai, Shaobo, et al.
Publicado: (2019)